Healthtech Startups

ExactCare is a pharmacy service that delivers medications to patients' homes while providing ongoing clinical support to optimize medication effectiveness and safety. The company works with insurance providers and doctors to manage patient medications and improve health outcomes.

2 investors

Examedi provides at-home blood tests and telemedicine consultations available 24/7 in Chile. The platform handles insurance reimbursement for users and offers clinical-quality health services at lower costs than traditional in-clinic visits.

2 investors

Excelin Health operates care delivery sites across California, Texas, and Louisiana, providing post-acute care services including home health, hospice, and private duty care.

2 investors

Eximis Surgical develops a minimally invasive specimen removal device for use in abdominal surgery, enabling surgeons to remove surgical specimens through small incisions rather than requiring larger incisions at the end of procedures. The device targets patients undergoing minimally invasive surgical procedures to reduce postoperative pain and recovery time.

2 investors

Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease. The company trains machine learning models on proprietary multimodal neuroscience data to guide its therapeutic screening process.

2 investors

Exonic develops machine learning models trained on biological data to predict gene therapy designs and genomic regulatory patterns, with initial applications in developing targeted treatments for liver cancer.

2 investors

2 investors

Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them. The founders describe backgrounds building manufacturing platforms and scaling production within the cell therapy industry.

2 investors

Eyas Medical Imaging develops MRI technology designed specifically for imaging babies and infants. The company serves healthcare professionals and hospitals seeking precision imaging solutions for neonatal and pediatric patients.

2 investors

Eye to Eye Telehealth develops technology to address data gaps in glaucoma care, working with engineers and clinicians to improve monitoring and treatment. It focuses on telehealth solutions for glaucoma management.

2 investors

EyeYon Medical develops medical devices for corneal diseases, including EndoArt®, a synthetic implant for chronic corneal edema, and HyperCL™, a therapeutic contact lens for enhancing drug absorption in corneal conditions. The company serves ophthalmologists and patients requiring alternatives to traditional corneal transplantation.

2 investors

EyeCare Partners operates a network of over 1,000 eye care providers across the United States, offering a full continuum of vision care services including ophthalmology and optometry. The doctor-led organization combines individual practice autonomy with centralized resources to improve patient outcomes and accessibility.

2 investors

EyeControl builds a communication and engagement platform for critical care, helping hospitals support patient recovery and connection between patients, families, and medical teams, with capabilities extending to home care. It originated as an eye-based communication tool for patients unable to speak, such as those with ALS and other neurological conditions.

2 investors

Eyemart Express operates a network of local optometry and eyewear retail stores, providing vision care and eyeglass sales to consumers in their communities. The company has been serving customers for over 34 years through a model emphasizing accessible, locally-focused customer service.

2 investors

Eyoto provides eye examination technology solutions for clinics, aiming to improve accessibility and efficiency of eye care delivery.

2 investors

Fable Therapeutics is a biotech company using protein engineering to develop biologics targeting the activin receptor type II (ActR2) pathway for obesity and related metabolic diseases. Its pipeline addresses body composition and broader metabolic health rather than weight loss alone, serving patients with obesity and cardiometabolic comorbidities.

2 investors

Fairly Staffing operates a platform and mobile app that connects dental temp professionals with clinics to handle temporary staffing. It serves the dental community, with a focus on Edmonton, Alberta, Canada.

2 investors

Fair Square Medicare is a licensed insurance brokerage that helps people turning 65 or otherwise eligible compare Medicare plans — including Medigap, Medicare Advantage, and Part D prescription drug plans — from multiple carriers and enroll in the option that fits their needs. It offers a free advisory service and reviews clients' plans annually to check for better coverage and value.

2 investors

Fairway Health provides an AI-powered solution for managing prior authorization processes in healthcare, helping payers reduce inefficiencies, delays, and costs.

2 investors

Farmacare is an operations management platform for pharmacies of all sizes in Indonesia, offering inventory management, purchasing from wholesalers, working capital access, and integrated electronic prescriptions through the government's SatuSehat system.

2 investors

Fast Pace Health operates a network of over 300 healthcare centers across eight rural U.S. states, offering urgent care, primary care, orthopedics, dermatology, behavioral health, physical therapy, and telehealth services to underserved communities. The company focuses on making quality, accessible healthcare available in small towns and rural areas where options are limited.

2 investors

Fasten builds a unified API platform for accessing patient medical records across health systems, replacing traditional methods like faxes and portal logins. The infrastructure serves clinical research, patient recruitment, and digital health applications.

2 investors

FASTinov develops phenotypic Antimicrobial Susceptibility Testing (AST) kits that deliver results within 2 hours directly from blood cultures, covering gram negative and gram positive panels. Its CE-marked in vitro diagnostic products serve clinical laboratories in the European Union.

2 investors

Fate Therapeutics develops investigational cellular immunotherapies to treat autoimmune diseases and cancer. The company is conducting clinical trials on product candidates under strict regulatory and ethical standards.

2 investors